Literature DB >> 30528841

Genetic analysis of neurodegenerative diseases in a pathology cohort.

Cornelis Blauwendraat1, Olga Pletnikova2, Joshua T Geiger1, Natalie A Murphy3, Yevgeniya Abramzon4, Gay Rudow2, Adamantios Mamais3, Marya S Sabir1, Barbara Crain2, Sarah Ahmed3, Liana S Rosenthal5, Catherine C Bakker5, Faraz Faghri6, Ruth Chia3, Jinhui Ding3, Ted M Dawson7, Alexander Pantelyat5, Marilyn S Albert5, Mike A Nalls8, Susan M Resnick9, Luigi Ferrucci10, Mark R Cookson3, Argye E Hillis5, Juan C Troncoso11, Sonja W Scholz12.   

Abstract

Molecular genetic research provides unprecedented opportunities to examine genotype-phenotype correlations underlying complex syndromes. To investigate pathogenic mutations and genotype-phenotype relationships in diverse neurodegenerative conditions, we performed a rare variant analysis of damaging mutations in autopsy-confirmed neurodegenerative cases from the Johns Hopkins Brain Resource Center (n = 1243 patients). We used NeuroChip genotyping and C9orf72 hexanucleotide repeat analysis to rapidly screen our cohort for disease-causing mutations. In total, we identified 42 individuals who carried a pathogenic mutation in LRRK2, GBA, APP, PSEN1, MAPT, GRN, C9orf72, SETX, SPAST, or CSF1R, and we provide a comprehensive description of the diverse clinicopathological features of these well-characterized cases. Our study highlights the utility of high-throughput genetic screening arrays to establish a molecular diagnosis in individuals with complex neurodegenerative syndromes, to broaden disease phenotypes and to provide insights into unexpected disease associations. Published by Elsevier Inc.

Entities:  

Keywords:  Brain bank; Genotype-phenotype; NeuroChip; Neurodegeneration

Mesh:

Substances:

Year:  2018        PMID: 30528841      PMCID: PMC6391207          DOI: 10.1016/j.neurobiolaging.2018.11.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  39 in total

1.  The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases.

Authors:  Dena Hernandez; Coro Paisan Ruiz; Anthony Crawley; Roneil Malkani; John Werner; Katrina Gwinn-Hardy; Dennis Dickson; Fabienne Wavrant Devrieze; John Hardy; Andrew Singleton
Journal:  Neurosci Lett       Date:  2005-12-09       Impact factor: 3.046

2.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

3.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

4.  An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype.

Authors:  Parvoneh Poorkaj; Nancy A Muma; Victoria Zhukareva; Elizabeth J Cochran; Kathleen M Shannon; Howard Hurtig; William C Koller; Thomas D Bird; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

5.  NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases.

Authors:  Cornelis Blauwendraat; Faraz Faghri; Lasse Pihlstrom; Joshua T Geiger; Alexis Elbaz; Suzanne Lesage; Jean-Christophe Corvol; Patrick May; Aude Nicolas; Yevgeniya Abramzon; Natalie A Murphy; J Raphael Gibbs; Mina Ryten; Raffaele Ferrari; Jose Bras; Rita Guerreiro; Julie Williams; Rebecca Sims; Steven Lubbe; Dena G Hernandez; Kin Y Mok; Laurie Robak; Roy H Campbell; Ekaterina Rogaeva; Bryan J Traynor; Ruth Chia; Sun Ju Chung; John A Hardy; Alexis Brice; Nicholas W Wood; Henry Houlden; Joshua M Shulman; Huw R Morris; Thomas Gasser; Rejko Krüger; Peter Heutink; Manu Sharma; Javier Simón-Sánchez; Mike A Nalls; Andrew B Singleton; Sonja W Scholz
Journal:  Neurobiol Aging       Date:  2017-05-17       Impact factor: 4.673

6.  Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series.

Authors:  Daniel McNaughton; William Knight; Rita Guerreiro; Natalie Ryan; Jessica Lowe; Mark Poulter; David J Nicholl; John Hardy; Tamas Revesz; James Lowe; Martin Rossor; John Collinge; Simon Mead
Journal:  Neurobiol Aging       Date:  2010-12-28       Impact factor: 4.673

7.  Identifying a high fraction of the human genome to be under selective constraint using GERP++.

Authors:  Eugene V Davydov; David L Goode; Marina Sirota; Gregory M Cooper; Arend Sidow; Serafim Batzoglou
Journal:  PLoS Comput Biol       Date:  2010-12-02       Impact factor: 4.475

Review 8.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

View more
  7 in total

Review 1.  Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism.

Authors:  Makaila L Furderer; Ellen Hertz; Grisel J Lopez; Ellen Sidransky
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

2.  Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology.

Authors:  Koyo Tsujikawa; Kohei Hamanaka; Yuichi Riku; Yuki Hattori; Norikazu Hara; Yohei Iguchi; Shinsuke Ishigaki; Atsushi Hashizume; Satoko Miyatake; Satomi Mitsuhashi; Yu Miyazaki; Mayumi Kataoka; Li Jiayi; Keizo Yasui; Satoshi Kuru; Haruki Koike; Kenta Kobayashi; Naruhiko Sahara; Norio Ozaki; Mari Yoshida; Akiyoshi Kakita; Yuko Saito; Yasushi Iwasaki; Akinori Miyashita; Takeshi Iwatsubo; Takeshi Ikeuchi; Takaki Miyata; Gen Sobue; Naomichi Matsumoto; Kentaro Sahashi; Masahisa Katsuno
Journal:  Sci Adv       Date:  2022-05-25       Impact factor: 14.957

Review 3.  The genetic architecture of Parkinson's disease.

Authors:  Cornelis Blauwendraat; Mike A Nalls; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2019-09-11       Impact factor: 44.182

Review 4.  Challenges in the diagnosis of Parkinson's disease.

Authors:  Eduardo Tolosa; Alicia Garrido; Sonja W Scholz; Werner Poewe
Journal:  Lancet Neurol       Date:  2021-05       Impact factor: 44.182

5.  Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease.

Authors:  Michael X Henderson; Medha Sengupta; John Q Trojanowski; Virginia M Y Lee
Journal:  Acta Neuropathol Commun       Date:  2019-11-16       Impact factor: 7.801

6.  Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor.

Authors:  Eli J Cornblath; Howard L Li; Lakshmi Changolkar; Bin Zhang; Hannah J Brown; Ronald J Gathagan; Modupe F Olufemi; John Q Trojanowski; Danielle S Bassett; Virginia M Y Lee; Michael X Henderson
Journal:  Sci Adv       Date:  2021-06-09       Impact factor: 14.136

Review 7.  Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.

Authors:  Aiko Robert; Michael Schöll; Thomas Vogels
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.